HSF1 and urinary bladder carcinoma: Western blotting (Fig. 7D) and immunohistochemical staining (Fig. 7E) results from tumor tissues demonstrated that silibinin suppressed bladder cancer growth through inhibiting HSF1/Hsp70 pathway.